IMNOVID caps 1 mg 21 pce

7680612490012 CH-61249 L04AX06 07.16.4.

Reimbursement limitations:

IMNOVID

Seulement après accord préalable sur la prise en charge des frais par la caisse maladie …

IMNOVID caps 1 mg 21 pce
IMNOVID caps 1 mg 21 pce
IMNOVID caps 1 mg 21 pce
1 / 3
google

Details

Product number
6124901
CPT
-
Packaging group
21
Unit
Kapsel(n)
Composition
pomalidomidum 1 mg, mannitolum, amylum pregelificatum, natrii stearylis fumaras corresp. natrium 0.018 mg, Kapselhülle: gelatina, E 171, E 132, E 172 (flavum), Drucktinte: lacca, E 171, simeticonum, propylenglycolum, ammoniae solutio 28 per centum, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.

Articles (1)

Imnovid 1 mg, Hartkapseln
Kapseln
21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/09/2023
Professional SmPC
Français
13/09/2023
Professional SmPC
Italien
13/09/2023
Patient information leaflet
Allemand
02/09/2022
Patient information leaflet
Français
02/09/2022
Patient information leaflet
Italien
02/09/2022

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.018 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 8226.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2014

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
61249
Drug name
Imnovid, Hartkapseln
Galenic form
KAHA
ATC Code
L04AX06
Authorization status
Z
Dispensation category
A
First authorization
02/06/2014
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Behandlung des Multiplen Myeloms

Packaging details

Description (FR)
IMNOVID caps 1 mg 21 pce
Description (DE)
IMNOVID Kaps 1 mg 21 Stk
Market launch
02/06/2014
Narcotic (BTM)
No

Available generics

Pomalidomid Accord, Hartkapseln
CHF 3415.75
View
Pomalidomid Accord, Hartkapseln
CHF 3460.10
View
Pomalidomid Accord, Hartkapseln
CHF 3504.45
View
Pomalidomid Accord, Hartkapseln
CHF 3534.10
View
Pomalidomid Sandoz, Hartkapseln
CHF 3415.75
View
Pomalidomid Sandoz, Hartkapseln
CHF 3460.10
View

Other packaging sizes

IMNOVID caps 2 mg 21 pce
21 KAP
View
IMNOVID caps 3 mg 21 pce
21 KAP
View
IMNOVID caps 4 mg 21 pce
21 KAP
View